Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2017

Mar 10, 2017

29831_dirs_2017-03-10_5893918a-65e0-4ec9-8c77-21c94033bf3e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2017-03-09

Reporting Person: JOHNSON RADY A (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-09 Common Stock I 4405.0000 $34.0500 Acquired 4821.0000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 59463.0000 Direct

Footnotes

F1: This transaction constitutes an intra-plan transfer involving the Pfizer stock fund under the Company's Qualified Savings Plan.